Published: Jun, 2018
Transparency Market Research in its recently published report on the global cardiac prosthetic devices market states that the market is extremely fragmented because of the presence of a copious number of players – both existing well-entrenched ones and upcoming ones. To stay ahead of competition in such a market, players are seen banking upon product development by leveraging the latest technologies.
Some of the companies that have come of hold substantial share in the market for cardiac prosthetic devices by banking upon the aforementioned and other strategies are Boston Scientific Corporation, Edwards Lifesciences Corporation, Sorin Group, Medtronic, Inc., and St. Jude Medical.
The report finds that rising at a healthy clip, the market’s estimated valuation would be US$5,290.0 million by 2019.
Cardiac prosthetic devices can be broadly classified into heart valves and pacemakers. While the pacemakers can be further segmented into heart valves and pacemakers, the heart valves can be further segmented into tissue heart valves, transcatheter heart valves, and mechanical heart valves. From a geographical standpoint, North America at present holds a leading share because of the superior technology, updated infrastructure, and presence of well-trained healthcare professional. Another factor stoking the market in the region is the rising instances of cardiovascular disease and sound healthcare and reimbursement policies.
Rising Pool of Elderly Highly Prone to Cardiac Conditions Drives Market
Cardiac prosthetics devices supplant diseased or damaged part of a body – they mainly find usage in tackling of blockages in heart valves. “Cardiac prosthetic devices implants are being widely adopted owing to the growth in the patients’ pool having valvular conditions. Prosthetic valve endocarditis (PVE), mechanical hemolytic anemia, prosthetic valve thrombosis (PVT), and thromboembolism are to name a few complications resulting from the failure of primary valves,” explains the lead analyst of our report.
The cardiac prosthetics devices serve to reduce mortality and morbidity rates by replacing the diseased valves. A heart valve disease, without timely treatment, can cause a variety heart ailments, namely heart failure, stroke, blood clots, and cardiac arrest. And with a rising number of geriatric population who are highly susceptible to cardiac issues and also because of the lifestyle changes leading to such health problems even in the younger lot, the devices are seeing swift uptake. Adds the lead analyst of our report, “Over 60, 000 patients are undergoing heart valve replacement in the U.S. annually. This has majorly fuelled demand for cardiac prosthetic devices.”
Focus on Product Development Bodes Well for Market
In addition to the surging cases of blockages in heart valves, the market for cardiac prosthetics devices is also being boosted by the continued thrust on product development. Major players are seen pouring money into research and development of better devices built from superior materials and underpinned by more sophisticated technologies.
On the flipside, the market is being negatively affected by the expensiveness of the products and the associated procedures.
This review is based on the findings of a TMR report, titled, “Cardiac Prosthetic Devices Market (Type – Heart Valves (Mechanical Heart Valves, Tissue Heart Valves (Stented Tissue Valve and Stentless Tissue Valve), and Transcatheter Heart Valves) and Pacemaker (Implantable Pacemaker and External Pacemaker) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013–2019.”
The report segments the Global Cardiac Prosthetics Devices Market into the following:
Global Cardiac Prosthetics Devices Market, by Type
- Heart Valves
- Mechanical Heart Valves
- Tissue Heart Valves
- Stented Tissue Valve
- Stentless Tissue Valve
- Transcatheter Heart Valves
- Implantable Pacemaker
- Single-Chamber Battery Pacemaker
- Dual-Chamber Battery Pacemaker
- Triple-Chamber Battery Pacemaker
- External Pacemaker
Global Cardiac Prosthetics Devices Market, by Region
- North America
- South America
- Asia Pacific
- Middle East and Africa
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453